Studies of troponin I level changes in patients with coronary artery disease after percutaneous coronary intervention

N Emukhvari1, E Tsetskhladze1, Kh Khijakadze1

  • 1Tbilisi State Medical University, A. Aladashvili University Clinic, Iinternal Medicine Department в"-1, Georgia.

Georgian Medical News
|January 25, 2015
PubMed

Insights

Troponin I (Tn I) levels before and after percutaneous coronary intervention (PCI) predict cardiovascular events in ischemic heart disease patients. Elevated Tn I indicates higher risks of complications and mortality.

Area of Science:

  • Cardiology
  • Biomarkers

Background:

  • Ischemic heart disease (IHD) poses significant cardiovascular risk.
  • Percutaneous coronary intervention (PCI) is a common treatment for IHD.
  • Troponin I (Tn I) is a cardiac biomarker used in diagnosing heart conditions.

Purpose of the Study:

  • To investigate the prognostic significance of Troponin I (Tn I) levels before and after PCI.
  • To correlate Tn I levels with cardiovascular event rates and mortality in IHD patients.

Main Methods:

  • Study involved 150 patients with ischemic heart disease.
  • Tn I levels were measured before and after PCI.
  • Cardiovascular events and mortality rates were tracked.

Main Results:

  • Normal Tn I levels pre- and post-PCI correlated with low cardiovascular event rates.
  • Elevated Tn I post-PCI was linked to increased complications, especially in those with high pre-PCI Tn I.
  • High Tn I pre-PCI predicted increased hospitalization and later mortality.
  • Tn I elevation post-PCI in patients with normal baseline levels predicted 30-day mortality more strongly than later mortality.

Conclusions:

  • Tn I levels before and after PCI are significant prognostic indicators in IHD.
  • Pre-PCI Tn I is associated with hospitalization and long-term mortality.
  • Post-PCI Tn I elevation is a critical predictor of short-term mortality.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.9K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
483
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
805
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
502
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
591